Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
4.8M | 1.74% | −7.5M (−60.7%) | 2021 | 0.0% | |
|
Shares held by quarter
Peak holding12.3M (Q1'26)
Change over 8 quarters−2.7M
Share of the company1.740%
|
||||||
|
VC
Vanguard Capital Management LLC
|
10.1M | 3.64% | +2.9M (+41.2%) | 2021 | 0.0% | |
|
Shares held by quarter
Peak holding10.1M (Q2'26)
Change over 8 quarters+10.1M
Share of the company3.640%
|
||||||
28 more super investors behind a free account
See every manager holding Humacyte Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$6.02M | 7.7M | 2.78% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$2.34M | 3.9M | 1.39% | 0.00% | March 31, 2026 |
23 more funds behind a free account
See every fund holding Humacyte Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FM
Fresenius Medical Care Holdings, Inc.
5%+ holder
13D · 4.9%
|
13.6M | 4.90% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
FM
Fresenius Medical Care AG
5%+ holder
13D · 4.9%
|
13.6M | 4.90% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
10 more holders behind a free account
See every insider and 5%+ holder of Humacyte Inc.
Sign up freeLoading...